口服黑种草油对超重和肥胖女性脂联素、PPAR-γ和TNF-α表达水平及血清浓度的影响:交叉设计、双盲、安慰剂对照随机临床试验的研究方案
本研究为交叉设计、双盲、安慰剂对照随机临床试验方案,拟纳入25-55岁、BMI 25-35 kg/m2的超重和肥胖女性,随机接受黑种草油胶囊或安慰剂每日两次、每次两粒(每粒1000 mg),干预8周后洗脱4周,再交换干预8周。主要评估黑种草油对TNF-α、PPAR-γ和脂联素基因表达及血清浓度的影响。
要点
- 研究对象为25-55岁、BMI 25-35 kg/m2的超重和肥胖女性。
- 干预为每日两粒黑种草油胶囊或安慰剂(每粒1000 mg),每阶段8周,洗脱期4周。
- 主要结局为TNF-α、PPAR-γ和脂联素的基因表达及血清浓度。
核心结论
- 本研究将探究黑种草油对超重和肥胖女性抗肥胖作用的可能细胞通路。
研究设计与样本
- 交叉设计、双盲、安慰剂对照随机临床试验方案,拟从Shahid Sadoughi医科大学肥胖门诊招募25-55岁、BMI 25-35 kg/m2的超重和肥胖女性。
- 参与者随机分为两组,每日接受两粒黑种草油胶囊或两粒安慰剂胶囊(每粒含1000 mg黑种草油或安慰剂),持续8周,经4周洗脱期后交换补充剂再干预8周。
- 在每阶段干预开始和结束时进行生化评估及实时聚合酶链反应检测基因表达。
主要发现
- 原文为研究方案,未报告研究结果。
关键数值与推荐
- 纳入标准:25-55岁超重和肥胖女性,BMI 25-35 kg/m2。
- 干预剂量:每日两粒胶囊,每粒含1000 mg黑种草油或安慰剂。
- 干预时长:每阶段8周,洗脱期4周。
- 主要评估指标:TNF-α、PPAR-γ和脂联素的基因表达及血清浓度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is a major public health problem in recent decades. The accumulation of excessive fat promotes inflammatory status. Meanwhile, herbal products are marketed for their weight-loss properties, such as Nigella sativa (N. Sativa) which has been used for centuries to treat rheumatoid arthritis, diabetes, and asthma; recently, the anti-obesity characteristics of N. sativa have also been indicated. However, the exact mechanisms and cellular-related pathways are still unclear. Thus, we will aim to assess the effects of oral N. sativa on the gene expression of inflammatory and adipogenesis-related factors, including TNF-α, PPAR-γ, and adiponectin as well as assessing their serum concentrations among obese and overweight individuals. METHODS: Obese and overweight women aged 25-55 years with a body mass index (BMI) of 25-35 kg/m2 will be recruited from the Obesity Clinic in Shahid Sadoughi University of Medical Sciences and will be assessed for eligibility against inclusion criteria. They will be randomly assigned into two groups to receive either two capsules of N. sativa or two capsules of placebo per day for eight weeks (each capsule contains 1000 mg of N. sativa or placebo). There will be a four-week wash-out period and then participants will receive the reverse supplements for another eight weeks. Biochemical assessments and gene expressions (using real-time polymerase chain reaction) will be conducted at the beginning and at the end of every intervention period. DISCUSSION: The present study will investigate the probable cellular pathways for the anti-obesity effects of N. sativa in overweight/obese women. TRIAL REGISTRATION: Iranian Registry of Clinical Trials, IRCT20180528039884N1 . Registered on 2nd of July, 2018.
引用
- Razmpoosh E, Safi S, Mazaheri M, et al. Effects of oral Nigella sativa oil on the expression levels and serum concentrations of adiponectin, PPAR-γ, and TNF-α in overweight and obese women: a study protocol for a crossover-designed, double-blind, placebo-controlled randomized clinical trial. Trials. 2019. PMID: 31420057. doi:10.1186/s13063-019-3568-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。